Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy

Transplantation

Volumn 95, Issue 10, 2013, Pages 1242-1248

  Agustian, Putri Andina ^a   Bockmeyer, Clemens Luitpold ^a   Modde, Friedrich ^a   Wittig, Juliane ^a   Heinemann, Falko Markus ^b   Brundiers, Stephanie ^a   Dämmrich, Maximilian Ernst ^a   Schwarz, Anke ^a   Birschmann, Ingvild ^a   Suwelack, Barbara ^c   Jindra, Peter Thomas ^d   Ahlenstiel, Thurid ^a   Wohlschläger, Jeremias ^b   Vester, Udo ^b   Ganzenmüller, Tina ^a   Zilian, Eva ^a   Feldkamp, Thorsten ^b   Spieker, Tilmann ^e   Immenschuh, Stephan ^a   Kreipe, Hans Heinrich ^a   Bröcker, Verena ^a   Becker, Jan Ulrich ^a   more..

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d ALBANY MEDICAL COLLEGE   (United States)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Complement; Microthrombosis; Thrombosis

Indexed keywords

CALCINEURIN INHIBITOR; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; KRUPPEL LIKE FACTOR 2; KRUPPEL LIKE FACTOR 4; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBRINOLYSIS; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLOMERULUS; GLOMERULUS CAPILLARY; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MICRODISSECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TISSUE SECTION;

ADAM PROTEINS; ADULT; AGED; CALCINEURIN; FEMALE; HUMANS; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; THROMBOTIC MICROANGIOPATHIES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84878562071     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318291a298     Document Type: Article

References (47)

1. Symmers WSC. Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). BMJ 1952; 2: 897.
2. Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010; 10: 1517.
3. Reynolds JC, Agodoa LY, Yuan CM, et al. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis 2003; 42: 1058.
4. Bresin E, Daina E, Noris M, et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 2006; 1: 88.
5. Kazatchkine M, Bariety J, Caen JP. The role of thrombosis in renal allograft rejection [author's translation]. Pathol Biol (Paris) 1976; 24: 497.
6. Mihatsch M, Gudat F, Ryffel B, et al. Cyclosporine nephropathy. In: Tisher CC, Brenner BM, eds. Renal Pathology. With Clinical and Functional Correlations, vol II. Philadelphia: JB Lippincott Co.; 1994.
7. Ponticelli C, Banfi G. Thrombotic microangiopathy after kidney transplantation. Transplant Int 2006; 19: 789.
8. Le Quintrec M, Lionet A, Kamar N, et al. Complement mutationassociated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant 2008; 8: 1694.
9. Wiman B, Collen D. Molecular mechanism of physiological fibrinolysis. Nature 1978; 272: 549.
10. Rezaie AR. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem 2001; 276: 15567.
11. Bergstein JM, Riley M, Bang NU. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. N Engl J Med 1992; 327: 755.
12. Sagripanti A, Carpi A, Baicchi U, et al. Plasmatic parameters of coagulation activation in thrombotic microangiopathy. Biomed Pharmacother 1996; 50: 357.
13. Anthony MT, Zeigler ZR, Lister J, et al. Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation. Am J Hematol 1998; 59: 9.
14. Martin AA, Woolven BL, Harris SJ, et al. Plasminogen activator inhibitor type-1 and interleukin-6 in haemolytic uraemic syndrome. J Paediatr Child Health 2000; 36: 327.
15. Van Geet C, Proesmans W, Arnout J, et al. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Kidney Int 1998; 54: 1324.
16. Rondeau E, Mougenot B, Lacave R, et al. Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies. Clin Nephrol 1990; 33: 55.
17. Xu Y, Hagege J, Mougenot B, et al. Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int 1996; 50: 2011.
18. Paueksakon P, Revelo MP, Ma LJ, et al. Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. Kidney Int 2002; 61: 2142.
19. Yamamoto K, Loskutoff DJ. The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. Am J Pathol 1997; 151: 725.
20. Rijken DC, Lijnen HR. New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost 2009; 7: 4.
21. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223.
22. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996; 87: 4235.
23. Nunez D, Charriaut-Marlangue C, Barel M, et al. Activation of human platelets through gp140, the C3d/EBV receptor (CR2). Eur J Immunol 1987; 17: 515.
24. Ozge-Anwar AH, Freedman JJ, Senyi AF, et al. Enhanced prothrombin- converting activity and factor Xa binding of platelets activated by the alternative complement pathway. Br J Haematol 1984; 57: 221.
25. Sims PJ, Faioni EM, Wiedmer T, et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205.
26. Wiedmer T, Esmon CT, Sims PJ. Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. Blood 1986; 68: 875.
27. Saadi S, Holzknecht RA, Patte CP, et al. Complement-mediated regulation of tissue factor activity in endothelium. J ExpMed 1995; 182: 1807.
28. Hamilton KK, Hattori R, Esmon CT, et al. Complement proteins C5b- 9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990; 265: 3809.
29. Lin Z, Kumar A, SenBanerjee S, et al. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 2005; 96: e48.
30. Zhang RJ, Yang LH, Zhang Y, et al. Effect of antisense KLF4 gene on the expression of vWF and PAI-1 in endothelium cells. Zhonghua Xue Ye Xue Za Zhi 2010; 31: 446.
31. Villarreal G Jr, Zhang Y, Larman HB, et al. Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. Biochem Biophys Res Commun 2010; 391: 984.
32. Wang W, Ha CH, Jhun BS, et al. Fluid shear stress stimulates phosphorylation- dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS. Blood 2010; 115: 2971.
33. Slater SC, Ramnath RD, Uttridge K, et al. Chronic exposure to laminar shear stress induces Kruppel-like factor 2 in glomerular endothelial cells and modulates interactions with co-cultured podocytes. Int J Biochem Cell Biol 2012; 44: 1482.
34. Fang Y, Davies PF. Site-specific microRNA-92a regulation of Kruppellike factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 2012; 32: 979.
35. Ali F, Hamdulay SS, Kinderlerer AR, et al. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppellike factor 2-dependent induction of heme oxygenase-1. J Thromb Haemost 2007; 5: 2537.
36. Cole JL, Housley GA Jr, Dykman TR, et al. Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci U S A 1985; 82: 859.
37. Seya T, Turner JR, Atkinson JP. Purification and characterization of a membrane protein (gp45Y70) that is a cofactor for cleavage of C3b and C4b. J Exp Med 1986; 163: 837.
38. Davies A, Simmons DL, Hale G, et al. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 1989; 170: 637.
39. Okada N, Harada R, Fujita T, et al. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1989; 1: 205.
40. Ploug M, Ronne E, Behrendt N, et al. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem1991; 266: 1926.
41. Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 1993; 15: 105.
42. Kinderlerer AR, Ali F, Johns M, et al. KLF2-dependent, shear stressinduced expression of CD59: a novel cytoprotective mechanism against complement-mediated injury in the vasculature. J Biol Chem 2008; 283: 14636.
43. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
44. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
45. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
46. Agustian PA, Schiffer M, Gwinner W, et al. Diminished Met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy. Am J Pathol 2011; 178: 2007.
47. Theophile K, Jonigk D, Kreipe H, et al. Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR. Diagn Mol Pathol 2008; 17: 101.